Full Text

Turn on search term navigation

© 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Purpose

Microscopic testicular sperm extraction is the most effective treatment for NOA, but the sperm retrieval rate is low and depends on testicular maturity. However, there are limited useful tests to assess testicular maturity. Chemical exchange saturation transfer (CEST) imaging is a new magnetic resonance imaging (MRI) technique that can image the distribution of trace substances in vivo. We focused on the potential role of creatine (Cr) in testes and hypothesized that Cr-CEST could indicate intratesticular spermatogenesis.

Methods

We performed Cr-CEST by using 7T MRI on wild-type C57B6/J mice and several types of male infertility models such as Sertoli-cell only (SCO) (Kitw/Kitwv), maturation arrest (MA) (Zfp541 knockout mouse and Kctd19 knockout mouse), and teratozoospermia (Tbc1d21 knockout mouse). After performing Cr-CEST, histological analysis was performed.

Results

The SCO and MA models showed decreased CEST signal intensity (p < 0.05), while no reduction was observed in the teratozoospermia model (p = 1.0). CEST signal intensity increased as the spermatogenesis stage progressed from the SCO model to the MA and teratozoospermia models. Furthermore, CEST signal intensity was reduced in 4-week-old wild-type mice with immature testes (p < 0.05).

Conclusions

This study suggests that Cr-CEST evaluates intratesticular spermatogenesis noninvasively and provides a new therapeutic strategy for treating male infertility.

Details

Title
Evaluation of the efficacy of creatine chemical exchange saturation transfer imaging in assessing testicular maturity
Author
Kuribayashi, Sohei 1   VIAFID ORCID Logo  ; Fukuhara, Shinichiro 1 ; Tsujimura, Go 1 ; Imanaka, Takahiro 1 ; Okada, Koichi 1 ; Ueda, Norichika 1 ; Takezawa, Kentaro 1 ; Kiuchi, Hiroshi 1 ; Saito, Shigeyoshi 2 ; Takahashi, Yusuke 3 ; Kioka, Hidetaka 4 ; Oura, Seiya 5 ; Shimada, Keisuke 5   VIAFID ORCID Logo  ; Ikawa, Masahito 6   VIAFID ORCID Logo  ; Nonomura, Norio 1 

 Department of Urology, Osaka University Graduate School of Medicine, Suita, Japan 
 Department of Medical Physics and Engineering, Division of Health Sciences, Osaka University Graduate School of Medicine, Suita, Japan; Department of Advanced Medical Technologies, National Cerebral and Cardiovascular Research Center, Suita, Japan 
 Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan; Department of Molecular Pharmacology, National Cerebral and Cardiovascular Center Research Institute, Suita, Japan 
 Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan 
 Research Institute for Microbial Diseases, Osaka University, Suita, Japan 
 Research Institute for Microbial Diseases, Osaka University, Suita, Japan; Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Japan 
Section
ORIGINAL ARTICLES
Publication year
2023
Publication date
Jan/Dec 2023
Publisher
John Wiley & Sons, Inc.
ISSN
14455781
e-ISSN
14470578
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2905671996
Copyright
© 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.